BreborowiczA., OreopoulosD.G.Physiological approaches to increase biocompatibility of peritoneal dialysis.Perit Dial Int.1995; 15(7, Suppl): S76–86.
4.
JörresA., WilliamsJ.O., TopleyN.Peritoneal dialysis solution biocompatibility: Inhibitory mechanisms and recent studies with bicarbonate-buffered solutions.Perit Dial Int.1997; 17(Suppl 2): S42–6.
5.
SchambyeH.T., FlesnerP., PedersenR.B., Hardt -MadsenM., ChemnitzJ., ChristensenH.K.Bicarbonateversus lactate-based CAPD fluids: A biocompatibility study in rabbits.Perit Dial Int.1992; 12: 281–6.
6.
Wieczorowska TobisK., KorybalskaK., PolubinskaA., RadkowskiM., BreborowiczA., MontagneA.Longterm effects of glycylglycine peritoneal dialysis solution with neutral pH on peritoneum in rats. In: KhannaR., ed. Advances in Peritoneal Dialysis.Toronto: Peritoneal Dialysis Publications, 1997; 13: 42–6.
7.
SuzukiK., KhannaR., NolphK.D., MooreH.L., TwardowskiZ.J.Effects of bicarbonate dialysis solution on peritoneal transport in rats. In: KhannaR., ed. Advances in Peritoneal Dialysis.Toronto: Peritoneal Dialysis Publications, 1996; 12: 24–6.
8.
MillerT.E., FindonG., RoweL.Characterization of an animal model of continuous peritoneal dialysis in chronic renal impairment.Clin Nephrol.1992; 37: 42–7.
9.
GotloibL., CrasswellerP., RodelaH., OreopoulosD.G., ZellermanG., OgilvieR.Experimental model for studies of continuous peritoneal dialysis in uremic rabbits.Nephron.1982; 31: 254–9.
10.
WieczorowskaK., KhannaR., MooreH.L., NolphK.D., TwardowskiZ.J.Reproducibility of peritoneal equilibration test (PET) in rats. In: KhannaR., ed. Advances in Peritoneal Dialysis.Toronto: Peritoneal Dialysis Publications, 1994; 10: 33–7.
11.
KuzlanM., PawlaczykK., Wieczorowska-TobisK., KorybalskaK., BreborowiczA., OreopoulosD.G.Peritoneal surface area and its permeability in rats.Perit Dial Int.1997; 17: 295–300.
12.
TranL.P., RodelaH., AbernethyN.J., YuanZ.Y., HayJ.B., OreopoulosD.G.Lymphatic drainage of hypertonic solution from the peritoneal cavity of anesthetized and conscious sheep.Am J Physiol.1993; 74: 859–67.
13.
BreborowiczA., KnapowskiJ.Augmentation of peritoneal dialysis clearances with procaine.Kidney Int.1984; 26: 392–6.
14.
BreborowiczA., KnapowskiJ.Local anesthetic Bupivacaine increases the peritoneal transport of solutes. Part I: In vivo study.Perit Dial Bull.1984; 4: 221–3.
15.
MooreH.L.Chronic catheter model for exchanges in the ambulatory rat.Perit Dial Int.1992; 12(Suppl 1): S141.
16.
Wieczorowska-TobisK., KorybalskaK., PolubinskaA., RadkowskiM., BreborowiczA., OreopoulosD.G.In vivo model to study the biocompatibility of peritoneal dialysis solutions.Int J Artif Organs.1997; 20: 673–7.
17.
GotloibL., WajsbrotV., ShostackA., KushnierR.Acute and long term changes in imprints of mice mesothelium exposed to glucose enriched lactated buffer dialysis solutions.Nephron.1995; 70: 466–77.
18.
RubinJ., JonesQ., QuillenE., BowerJ.D.A model oflongterm peritoneal dialysis in the dog.Nephron.1983; 35: 259–63.
19.
Wieczorowska-TobisK., PolubinskaA., PawlaczykK., KuzlanM., BreborowiczA., OreopoulosD.G.The effect of glucose concentration in peritoneal dialysis fluid on peritoneal healing after catheter insertion in rats.Perit Dial Int.1998; 18(Suppl 1): S9.
20.
RubinJ., RustP., BrownP., PopovichR.P., NolphK.D.Comparison of peritoneal transport in patients with psoriasis and uremia.Nephron.1981; 29: 185–9.
21.
SuzukiK., NamotoS., KarinoT., WadaM.Effects ofrenal function on peritoneal transport properties in rats.Perit Dial Int.1998; 18(Suppl 1): S7.
22.
HirszelP., LameireN., BogaertM.Pharmacologic alterations of peritoneal transport rates and pharmacokinetics of the peritoneum. In: GokalR., NolphK.D., eds. The Textbook of Peritoneal Dialysis.Dordrecht: Kluwer Academic Publishers; 1994: 161–232.
23.
AbemethyN.J., ChinW., HayJ.B., KimptonW.G., WashingtonE., CahillR.N.Lymphatic drainage of the peritoneal cavity in sheep.Am J Physiol.1991; 260: F353–8.
24.
KimM., LofthouseJ., FlessnerM.F.A method to test blood flow limitation of peritoneal-blood solute transport.J Am Soc Nephrol.1997; 8: 471–4.
25.
SlaterN.D., CopeG.H., RafteryA.T.Mesothelial hyperplasia in response to peritoneal dialysis fluid: A morphometric study in the rat.Nephron.1991; 58: 466–71.
26.
SlaterN.D., CopeG.H., RafteryA.T.Peritoneal ultrafiltration after chronic exposure to dialysis fluid.Perit Dial Int.1992; 12: 48–50.
27.
WuG., Wieczorowska-TobisK., PolubinskaA., KorybalskaK., FilasV., TamP.N-Acetylglucosamine changes permeability of peritoneum during chronic peritoneal dialysis in rats.Perit Dial Int.1998; 18: 217–24.
28.
Di PaoloN., GarosiG., PetriniG., TraversariL., RossiP.Peritoneal dialysis solution biocompatibility testing in animals.Perit Dial Int.1995; 15(7, Suppl): S61–70.
29.
FlessnerM.F.The importance of the interstitium in peritoneal transport.Perit Dial Int.1996; 16(Suppl 1): S76–9.
30.
DobbieJ.W.Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis.Perit Dial Int.1992; 12: 14–27.
